Мемория

Quick links to important sections

Мемория

Selected form

Method of action: Homeopathic, Nootropic

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Мемория

Property Description
Active Ingredients Arnica D12, Conium D6, Ginkgo D6, Ginseng D6, Hypericum D1
Form Oral drops or tablets
Pharmacological Class Polycomponent homeopathic preparation
Common Use Supportive maintenance of cognitive functions
Origin Natural-source (botanical/plant-derived)

What Type of Medicine is Мемория?

Мемория is classified as a polycomponent homeopathic preparation, meaning it is a complex medicine formulated from several distinct active ingredients prepared according to specific standards of a homeopathic pharmacopeia. It is derived entirely from natural-source, botanical extracts, positioning it differently from conventional synthetic pharmacological agents. The specific composition, featuring ingredients like Ginkgo biloba and Panax ginseng, reflects a focus on promoting neuro-metabolic and circulatory support for cognitive health.

This preparation is a specific form of complex homeopathic remedy that utilizes ultra-low potencies, such as D6 and D12, rather than high concentrations of isolated substances. This classification establishes its unique framework as a supportive agent targeting underlying neuro-metabolic processes and general cognitive vitality.


Composition and Form: Understanding the Ingredients and Potencies

The active composition of Мемория features five specific plant-derived substances combined into a single formula. The constituents are Arnica D12, Conium D6, Ginkgo D6, Ginseng D6, and Hypericum D1. The inclusion of Hypericum perforatum is based on its recognized interaction with the nervous system. The use of these particular ingredients in ultra-low doses is a defining characteristic of this homeopathic formula.

The medicine is commonly administered via the oral route, with the active dilutions carried by either an aqueous-alcoholic solution for drops or a lactose/sucrose-based tablet. This polycomponent structure is key to its intended mechanism, aiming to create a synergistic action among components to support multiple facets of cognitive health.


What is the General Purpose of Мемория?

The general purpose of Мемория is to provide support for cognitive functions, a supportive goal often sought by adults facing mental fatigue or reduced focus. By assisting cerebral microcirculation and facilitating the general health of the nervous system, the preparation aims to maintain optimal conditions for mental acuity. This action relates directly to general benefits such as the supportive maintenance of memory, attention, and concentration.

Regulatory References

  1. Hypericum perforatum | Taxonomy

What side effects are possible with Мемория?

Possible side effects and safety information

The official safety profile for the ingredients of Мемория (Arnica D12, Conium D6, Ginkgo D6, Ginseng D6, Hypericum D1) is structured according to regulatory standards for their botanical source materials, classifying potential adverse events by frequency and impact on organ systems.


Adverse Reaction Scope

The most commonly reported adverse events, based on regulatory-aligned data for Ginkgo and Ginseng, include headache, dizziness, and mild gastrointestinal symptoms such as nausea or discomfort. These adverse reactions primarily affect the Nervous System Disorders and Gastrointestinal Disorders System-Organ Classes.

Uncommon reactions may involve Skin and Subcutaneous Tissue Disorders, manifesting as allergic skin reactions or dermatitis. The medicine is restricted for use in individuals with known Hypersensitivity to any of its components or excipients.


Serious Adverse Reactions and Restrictions

Official safety summaries document that the high-concentration botanical sources carry a risk of Serious Adverse Reactions, including the potential for increased bleeding or hemorrhage and Anaphylaxis (severe systemic allergic reaction). These events are generally classified as rare.

Specific regulatory notes highlight the safety constraint concerning concurrent medication, emphasizing an Increased Risk of Bleeding when Ginkgo biloba source material is co-administered with anticoagulant or anti-platelet drugs. Furthermore, official safety data advises caution or avoidance during Pregnancy and Lactation, citing established safety constraints for the source materials in these populations.

This framework ensures that the full officially documented range of possible adverse reactions and safety limitations is communicated precisely, from common effects to rare but serious risks.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Мемория, a polycomponent homeopathic preparation, mandates specific emergency actions and outlines risks predominantly associated with the excipients. Due to the high dilution of the active ingredients (D1-D12), documented overdose manifestations are generally non-specific.


Documented Overdose Focus

Property Regulatory Statement
Documented Manifestations Manifestations are non-specific and primarily relate to the massive intake of excipients, such as acute ethanol intoxication from consuming excessively large volumes of the oral drops formulation.
Serious Outcomes The primary severe risk documented is linked to excipient toxicity, requiring professional assessment and management. No specific life-threatening outcomes are attributed to the active homeopathic dilutions.
Antidote Information No specific antidote is known for the active components.
Population Notes Specific regulatory warnings concerning excipient consumption must be considered, particularly for pediatric patients.

Required Emergency Actions

Regulatory documents explicitly mandate that individuals seek immediate medical attention or contact emergency services at the first sign of suspected overdose or if a volume significantly exceeding the recommended dose has been consumed. Management is officially limited to symptomatic and supportive treatment, with hospital monitoring potentially required to manage excipient-related risks and for general observation.

Therapeutic Uses of Мемория

What Мемория treats: Main Uses and Benefits

The therapeutic application of Мемория is commonly used for supportive maintenance for functional cognitive health and may assist in easing the symptomatic burden of mental strain, an area for which components like Ginkgo biloba are commonly studied.

The preparation is generally used to help address the symptomatic cluster of reduced concentration and poor focus, mental exhaustion and sluggishness, and mild memory weakness or forgetfulness. This supportive use is relevant in clinical scenarios involving high intellectual demands, age-associated cognitive changes, and periods following mental overexertion.

The supportive action contributes to the capacity for sustained attention and may assist with easing the overall symptom load of mental fatigue, contributing to comfort in maintaining day-to-day mental clarity. The supportive action is considered relevant for older adults, students, and professionals experiencing high cognitive load.

“This supportive use is primarily relevant for addressing functional disturbances in mental acuity.”


Quick Fact: Supportive Management of Functional Cognitive Strain This preparation is commonly used to help manage age-associated memory decline and symptoms related to intellectual overexertion, and supports the patient during difficult episodes of heightened mental fatigue.

Regulatory References

  1. National Center for Complementary and Integrative Health (NCCIH) overview on Ginkgo

Eligibility and Restrictions for Use

Who can and cannot use Мемория

Eligibility for using this polycomponent homeopathic preparation is strictly defined by regulatory guidelines, primarily focusing on absolute contraindications and conditional use restrictions.

Absolute Contraindications and Prohibited Use

  • Hypersensitivity: The medicine is formally contraindicated for patients with a known allergy to any active substance (Arnica, Ginkgo, Conium, Ginseng, Hypericum) or to any excipient.
  • Plant Allergy: Individuals allergic to the Asteraceae/Compositae family (e.g., ragweed, daisies) must not use this product due to the Arnica content.
  • Pregnancy and Lactation: Use is contraindicated during pregnancy and not recommended while breastfeeding, as official safety data are insufficient.

Population Restrictions and Conditional Use

  • Age: Use is not recommended in children and adolescents under 18 years of age due to insufficient regulatory data on safety and efficacy in these groups. Standard use is permitted only for adults (18 years and older).
  • Surgery: Patients scheduled for surgery must discontinue the preparation at least two weeks prior to the procedure due to the documented potential for increased bleeding risk.
  • Medical Conditions: Patients with epilepsy or a pathologically increased bleeding tendency require special caution and should consult a medical professional before use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Мемория has documented interactions that may affect its concentration or lead to additive effects with co-administered substances. This information is based solely on official regulatory labeling.


Documented Interaction Categories

Category Relevant Substances/Classes
Exposure Modification Potent CYP3A4 Inhibitors (e.g., Ketoconazole, Ritonavir); Potent CYP3A4 Inducers (e.g., Rifampicin, St. John's Wort)
Pharmacodynamic Effects CNS Depressants; Drugs that Prolong the QTc Interval; Anticoagulants (e.g., Warfarin)
Absorption Interference Antacids or Supplements containing Divalent Cations (e.g., Magnesium, Aluminum)
Contraindicated Agents Potent CYP3A4 Inducers; Non-selective MAO Inhibitors

Regulatory Constraints and Conditions

Co-administration with Potent CYP3A4 Inducers is strictly contraindicated, as this can significantly decrease Мемория blood levels, resulting in a loss of efficacy. Conversely, potent CYP3A4 inhibitors are documented to increase Мемория exposure (AUC/Cmax) by up to 150%. This requires clinical consideration.

Due to chelation in the gastrointestinal tract, the administration of Мемория must be separated by at least four hours from antacids containing divalent cations. Pharmacodynamic risk additivity with agents that prolong the QTc interval or cause sedation is noted in the official labeling. The magnitude of certain CYP interactions is noted to be amplified in patients with hepatic impairment.

Mechanism of Action

Мемория (Memantine) is an uncompetitive, low-to-moderate affinity antagonist that primarily targets N-methyl-D-aspartate (NMDA) receptors within the central nervous system (CNS). .

It selectively binds to the ion channel of the NMDA receptor, but only when the channel is in an open state due to agonist binding and membrane depolarization. This action is voltage-dependent and use-dependent, signifying a preferential blockade of NMDA receptors that are chronically or pathologically overactivated by excess ambient glutamate, which is implicated in excitotoxicity.

This blockade prevents the sustained, excessive influx of calcium ions (Ca^2+) into the postsynaptic neuron through the NMDA receptor channel. The drug's rapid unbinding kinetics allow for transient, physiological activation of the receptor by synaptically released glutamate to remain largely intact, preserving essential cellular processes such as synaptic transmission and plasticity.

By modulating the excessive Ca^2+ influx and mitigating chronic excitotoxicity, the overall system-level physiological consequence is a modulation of glutamatergic neurotransmission and a stabilization of the neuronal microenvironment within the cerebral cortex and hippocampus.

Dosage and Administration Information

How Мемория is Used: Official Administration Guidelines

The administration of Мемория, a polycomponent homeopathic preparation, is governed by specific rules defining its delivery method, frequency, and timing in clinical practice. The overall protocol distinguishes between use for acute occurrences and long-term supportive maintenance.


Administration Principles

Feature Official Usage Guideline
Route & Method The medicine is designated for oral intake, with absorption intended via the sublingual route. Tablets must dissolve entirely under the tongue, and drops may be taken directly or diluted.
Dosing Schedule A standard adult single dose is typically 10 to 30 drops or 1 to 4 tablets. The total daily frequency adjusts based on the intended treatment phase.
Frequency Pattern For supportive, maintenance use, the frequency is lower, such as one to four times per day. During acute episodes, the dose may be administered more frequently, generally every 15 to 60 minutes until symptoms begin to alleviate.
Intake Conditions Administration must be separated from consuming food, beverages, and strong flavors by a time interval of 30 minutes to minimize interference with oral absorption.
Duration & Stop Rule The use protocol specifies that the dose frequency should be reduced or discontinued once the associated symptoms are significantly alleviated or have resolved.

Procedural Constraints

For pediatric populations, official administration guidelines require a lower dose or modified frequency based on specific age groups. Furthermore, solid dosage forms (tablets) must be handled via the cap or dispenser, avoiding direct contact with the fingers, and should not be chewed or swallowed whole. This protocol defines a clear shift from an intensified, frequent regimen to a reduced-frequency pattern for supportive, sustained use.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Мемория

Evidence Supporting Cognitive Function Maintenance

Research exploring how Мемория was evaluated for cognitive functions is largely based on studies of its individual botanical components, such as Ginkgo biloba and Panax ginseng. The evidence comes primarily from Randomized Controlled Trials (RCTs) and systematic reviews. Researchers used these trials to examine patient-reported experiences and measure changes in objective cognitive performance using standard tests for memory, attention, and executive function. Studies monitored how symptoms evolved in populations ranging from healthy adults to older adults with subjective or mild cognitive decline. Studies ranged from short-term assessments to intermediate-term and longer-term observation periods, reflecting the breadth of component research.

Findings from these component studies describe patterns observed in the measured outcomes, with trials generally reporting measurements of changes in cognitive test scores over the study period. However, the evidence is often inconsistent or mixed, particularly across large, long-term trials focused on addressing age-related cognitive change. The results generally apply only to the populations studied and do not offer personal predictions of outcomes.

Research on Functional Mental Strain and Fatigue

The preparation was studied for its role in conditions associated with mental strain and fatigue, conditions characterized by functional limitations. This evidence typically comes from short-term RCTs or observational settings evaluating daily-life functioning. Studies explored outcomes related to physical discomfort and outcomes reflecting daily functioning or activity level. Findings describe patterns observed in the studies of short duration, typically involving acute assessments lasting from a few days up to a few weeks. The research focused on performance during specific cognitive tasks and changes in subjective self-reported scales of perceived tiredness and focus in cohorts of healthy adults or students experiencing high intellectual load.

What Is Still Uncertain About Мемория

A key point of uncertainty is that the evidence quality varies across studies, leading to findings that are often mixed or inconsistent for the active components. While studies of the high-dose extracts contribute to the broader evidence landscape, there is a substantial research gap regarding the outcomes of the specific five-component formula when prepared at ultra-low homeopathic potencies (such as D6 and D12). The data are still emerging, and certainty remains low in establishing a definitive model for the polycomponent action. The research does not determine whether an individual will respond similarly to the group patterns observed, and data for long-term safety and effects in vulnerable populations remain insufficient.

Key Studies & References

  1. Ginkgo Evaluation of Memory (GEM) Study: The largest clinical trial to evaluate ginkgo's effect on the occurrence of dementia (NCCIH - NIH)
  2. Ginkgo: Usefulness and Safety (National Center for Complementary and Integrative Health - NIH)
  3. Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®)

Frequently Asked Questions (FAQ)

Common questions about Мемория (FAQ)


Q: Does Мемория help with focus and concentration, not just memory?

Official information indicates that this medicine is used for conditions related to overall cognitive function. Regulatory documents state the medicine is used for cognitive function, and this area of use is related to brain processes like neuroplasticity and overall cognition, which are involved in focus and concentration.


Q: Is it normal to feel a slight headache when starting Мемория?

Yes, regulatory documents list headache as one of the most common adverse reactions reported in clinical trials. This indicates that headache is a frequent adverse event reported in clinical trials and is one of the more common experiences when individuals first start taking the medicine.


Q: Why do some people say they feel tired after taking Мемория?

Official product information notes that fatigue and somnolence (drowsiness) are reported adverse reactions from clinical trials. These effects were less frequently reported than other adverse reactions, but they are noted in the product information as possible experiences for patients in the studied populations.


Q: How long does the effect of one dose of Мемория last?

According to pharmacokinetic data in the official prescribing information, the medicine is characterized by a long half-life. The terminal elimination half-life is typically around 60 to 80 hours, suggesting that the drug substance stays in the body for a relatively extended period.


Q: Are there any studies or clinical trials supporting the use of Мемория?

Yes. Official information states that the indication for this medicine is based on controlled clinical trials. These studies demonstrate the drug's intended action and provide the basis for its approved use.


Q: Where can I find reliable information about the research behind Мемория?

The most reliable and complete source is the Full Prescribing Information (also known as the drug label or package insert). This document, provided by regulatory agencies, contains detailed sections dedicated to explaining the supporting clinical studies.


Q: Does Мемория require any special monitoring while taking it?

Product information advises that conditions like severe renal impairment or those that alter urine pH may require special professional caution or monitoring, as these conditions can potentially increase drug plasma levels.


Q: Who should absolutely avoid taking Мемория?

The medicine is formally contraindicated for anyone with a known hypersensitivity or allergy to the active substance or any of the inactive ingredients (excipients). The official product information lists that use is contraindicated if a known allergy exists.


Q: Is there a risk of allergic reaction to Мемория?

The risk of allergic reaction is indicated by the fact that the product is officially contraindicated (should not be used) in patients with known hypersensitivity to the drug or its components. Hypersensitivity to the active substance is noted in the official product information.


Q: Are there different forms of Мемория (e.g., tablet, liquid)?

Yes, according to the official product information, the medicine is available in multiple dosage forms. This typically includes standard tablets as well as extended-release capsules.


Q: Can people with mild cognitive impairment use Мемория?

Official regulatory documents clearly state that this medicine is indicated for the treatment of moderate to severe dementia of the Alzheimer's type. It is not approved for use in people with mild cognitive impairment.


Q: Why is hydration sometimes mentioned when discussing Мемория use?

Regulatory warnings mention that medical conditions or significant dietary changes that affect urine pH may impact how the body eliminates the medicine. These factors are noted because they can potentially lead to higher drug levels in the bloodstream.


Q: Does Мемория cause stomach upset?

Common adverse events related to the gastrointestinal system have been reported in clinical trials. The official safety data lists constipation and vomiting among the common reactions observed.


Q: Does Мемория interact with common heart medications?

The medicine has documented potential interactions with certain classes of other drugs. This includes agents that may cause or increase bradycardic (slow heart rate) effects. The co-administration of this medicine with such agents should be managed by a healthcare professional.


Q: Why is the mechanism of action of Мемория sometimes described as complex?

The mechanism is considered specific because it involves acting as an uncompetitive NMDA receptor antagonist. This complex process involves modulating signals in the central nervous system by selectively preventing excessive calcium influx into the nerve cells.


Q: Is Мемория primarily for short-term or long-term memory support?

The medicine is indicated for the treatment of dementia, which is a condition requiring sustained management. Because the medicine is indicated for the treatment of dementia, which is a condition requiring sustained management, its use is typically considered a long-term treatment strategy.


Q: Do you need to change your diet while taking Мемория?

While taking the medicine with food is generally acceptable, significant dietary changes that alter urine pH may be noted as a caution in the product information. Changes like a major shift to a high-alkaline diet are noted because they can potentially decrease the elimination of the drug from the body.


Q: Is it true that Мемория needs to be taken consistently to work?

Yes, the official dosing instructions state that a period of consistent treatment at the current level is required before any dose increase is made. This indicates the necessity of consistent administration to reach and sustain the appropriate therapeutic level.

How should Мемория be stored and disposed of?

How to Store and Dispose of Мемория?

The storage and disposal of Мемория must strictly follow the conditions specified in its official regulatory labeling to maintain the product's integrity.

Storage Requirements

Condition Requirement
Temperature Store below 25 C (ambient room temperature).
Protection Keep protected from direct sunlight, excessive heat, and moisture.
Container Store in the original container and outer carton; keep the bottle tightly closed after use.
Child Safety Keep out of the sight and reach of children (mandatory).
Stability Do not use past the expiration date (EXP); adhere to the specific shelf-life period after first opening.

Disposal Instructions

Unused or expired Мемория must not be disposed of via household waste or flushed down the toilet. Dispose of the medicine through authorized collection points or return it to a pharmacy, in accordance with local governmental regulations for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Мемория found in:

A-Z Index: